Cargando…

Response to the comment by Dr Yarlas

Detalles Bibliográficos
Autor principal: Aimo, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285538/
https://www.ncbi.nlm.nih.gov/pubmed/34293200
http://dx.doi.org/10.1111/eci.13652
_version_ 1784747806637948928
author Aimo, Alberto
author_facet Aimo, Alberto
author_sort Aimo, Alberto
collection PubMed
description
format Online
Article
Text
id pubmed-9285538
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92855382022-07-18 Response to the comment by Dr Yarlas Aimo, Alberto Eur J Clin Invest Letters John Wiley and Sons Inc. 2021-07-28 2021-11 /pmc/articles/PMC9285538/ /pubmed/34293200 http://dx.doi.org/10.1111/eci.13652 Text en © 2021 The Authors. European Journal of Clinical Investigation published by John Wiley & Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters
Aimo, Alberto
Response to the comment by Dr Yarlas
title Response to the comment by Dr Yarlas
title_full Response to the comment by Dr Yarlas
title_fullStr Response to the comment by Dr Yarlas
title_full_unstemmed Response to the comment by Dr Yarlas
title_short Response to the comment by Dr Yarlas
title_sort response to the comment by dr yarlas
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285538/
https://www.ncbi.nlm.nih.gov/pubmed/34293200
http://dx.doi.org/10.1111/eci.13652
work_keys_str_mv AT aimoalberto responsetothecommentbydryarlas